Biomm Reaffirms 2026 EBITDA Guidance of R$ 90 Million to R$ 100 Million

Bitget2026/11/06 11:16

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Biomm remains confident in its 2026 EBITDA guidance of R$ 90 million–R$ 100 million, potentially reaching the lower bound in November.
October results slightly exceeded expectations, with public-sector insulin revenue reaching R$ 96.57 million versus R$ 5.87 million in October 2025.
Combined September–October revenue exceeded first-half revenue by 16%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIOMM SA published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biomm Reaffirms 2026 EBITDA Guidance of R$ 90 Million to R$ 100 Million

You may also like

Crypto prices